ATG5 and metabolic dysfunction-associated steatotic liver disease: For example, murine models of obesity and NAFLD, such as those involving high-fat diet-based feeding or the genetic manipulation of PNPLA3 [51] and ATG5 [52], have revealed key mechanisms driving lipid accumulation and mitochondrial dysfunction.